Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) in Chile
Total 0 results
Nothing found
Sponsors and Collaborators
Metabolic Research Unit
KAI Pharmaceuticals
Medical Information Technology (MedIT), RWTH Aachen University
Canadian Cystic Fibrosis Foundation
CrashCourse AB
M.p. van den Berg, MD, PhD, professor in Cardiology
MMJ Labs LLC
Dr. Melody Smith, MD, MS
See You At The Summit
Kansas City Bioanalytical Laboratories
Tianjin Chasesun Pharmaceutical Co., LTD
Harvard-NIOSH Education and Research Center (ERC)
Miami Cardiac and Vascular Institute
Tweddle Child and Family Health Service
Athersys, Inc
Colegio Oficial de Enfermeras y Enfermeros de Barcelona
Unitat d'Hemostasia i Trombosi. Hospital de la Santa Creu i Sant Pau
Zhejiang Rehabilitation Center
Magdalena Salcedo
Sociedad Española de Cirugía Torácica
View Full List
Medical Conditions
Combretastatin A4 Phosphate
Peripheral Microvascular Symptoms
Unresectable Stage III or IV Malignant Melanoma
Pesticide-Induced Parkinsonism
Oropharyngeal Basaloid Carcinoma
Older People With Cardiovascular Disease Risk
Neoplasia; Intraepithelial, Cervix
Stage III Melanoma
Advanced Thymic Epithelial Tumor
Hepatitis A Virus Infection
Peripheral Primitive Neuroectodermal Tumor of Bone
Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale)
Malignant Tumor
Skin Androgenization
Ingrown Toenail
Stage II Ovary Cancer
Discrete Choice Experiment
Thoraric Surgery
Anaplastic Lymphoma Kinase Gene Mutation
Ductal Carcinomas
View Full List
Drug Interventions
TV-46046 - 300 mg/mL (if warranted)
Botox
Chloroquine (CQ) prophylaxis
Ruxolitinib
Paracetamol
9-aminocamptothecin
Usual care
Group A propofol + remifentanil
IPX203 280 mg
Toripalimab
Marijuana
Simvastatin 10mg
CSII,ALA,MET,RSG
Thrombolytic Therapy
Cabotegravir, Rilpivirine Drug Combination
Triamcinolone
0/0mg taken first
HB0030 injection
Binimetinib Pill
LC Bead loaded with doxorubicin
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Armenia
Contract Research Organizations in France
Contract Research Organizations in Greece
Contract Research Organizations in Hungary
Contract Research Organizations in Ireland
Contract Research Organizations in Kenya
Contract Research Organizations in Kosovo
Contract Research Organizations in Mexico
Contract Research Organizations in Netherlands
Contract Research Organizations in New Zealand
Contract Research Organizations in Serbia
Contract Research Organizations in United Arab Emirates
CRO list by country
CROs in Switzerland
Parexel
Cepha
IQVIA
OPIS
PSI
AGINKO Research AG
DRK Pharma Solutions
ICON
Caidya
Celerion
All CROs in Switzerland
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe